- Home
- IHT vs NCEL Comparison
IHT vs NCEL Comparison
Compare IHT & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IHT | NCEL |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 12.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IHT | NCEL |
|---|---|---|
| Price | $1.22 | $3.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.5K | ★ 185.3K |
| Earning Date | 12-15-2025 | 12-01-2025 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,443,699.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.05 | $1.89 |
| 52 Week High | $4.24 | $7.64 |
Technical Indicators
Market Signals| Indicator | IHT | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 61.86 |
| Support Level | $1.16 | $2.62 |
| Resistance Level | $1.23 | $2.86 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 72.00 | 88.31 |
Price Performance
Historical ComparisonAbout IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.